We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/7/2015 08:12 | Different set of problems... becomes unstable after 5 weeks in storage at room temperature (is that in the UK lab or in a hut in sub saharan africa). Disappointing to say the least. | spacecake | |
07/7/2015 08:12 | Lol hi Barry only a matter of waiting till things sorted don't know why people panic you would think they are a one product company | leedslad001 | |
07/7/2015 08:04 | Morning All, Well that went well!!!! | barrywhit | |
02/7/2015 12:33 | The 7th July should be informative and may give us a timeline for progress. I added yesterday and perhaps there may be a small run up to the results. | pdt | |
28/6/2015 15:38 | Results 7th July should get a full update | leedslad001 | |
16/6/2015 12:02 | Omega Diagnostics’ Group Scientific Director, Nigel Abrahams, discusses the key differences between allergy and intolerance, explains the differences between IgE and IgG, and introduces Food Detective™, the world's first self test for food intolerance, at medicine-based gluten & FIT seminar in Hong Kong. …/hxxp://beike I like the worlds first bit. So much depth to this company. | leedslad001 | |
15/6/2015 17:32 | Looks like the share price is heading south to greece. | spacecake | |
10/6/2015 14:57 | ??? were to now !! | farmsted | |
05/6/2015 11:11 | Morning All, All heading in the right direction, I thought the 100k buy the other day would have been a Director buy, obviously not, well done Richard Sneller... | barrywhit | |
05/6/2015 10:41 | Richard Sneller has heavily increased his stake in ODX to 4.4m from his prior disclosure in March last year of 3.3m and is now above 4%: Interestingly, he seems to be a Fund Manager at Baillie Gifford, so knows his way around small companies: | rivaldo | |
05/6/2015 08:25 | Performing well at present. Lots to go for still though. | rivaldo | |
02/6/2015 16:04 | Old article but shows the quantity of testing potentially available to ODX, | barrywhit | |
01/6/2015 19:17 | A profit is always a profit. Can't begrudge someone selling when they want to. | longshanks | |
01/6/2015 18:49 | Their name says it all!!!! No wonder we didn't keep the rise looking at the last 2 delayed sells.... | barrywhit | |
01/6/2015 18:20 | Did anyone read that Motley Fool article - where do they get these muppets from?? | longshanks | |
01/6/2015 09:15 | Longshanks / Barrywhit - thanks for your replies, appreciated. If it hits 50p in 12 months time I would be delighted. | pdt | |
01/6/2015 08:50 | We may well see Broker Note upgrades after todays RNS..... | barrywhit | |
01/6/2015 08:42 | Can't buy in any volume, looks like some-one is buying in 5k batches.... | barrywhit | |
01/6/2015 08:34 | CE approval won't take long - it should be a fairly straightforward process; there are no moving parts or child usage issues.Field trials could take 3-4 months - so I would pencil in limited sales (if any) for this FY. But this is all about FY16+ and the sales growth should be rapid. Margins will be very high and it should turn a very decent profit that will go straight to the bottom line.ISYS based sales of allergens will be less profitable but will add another good string to what is already a fairly diverse bow of commercial operations.The new COO appointment is a good sign too as where CD4 leads, other potential markets are available for the Visitek handheld device: he will be key to developing those markets/opportunitie | longshanks | |
01/6/2015 08:22 | PDT, Difficult to say after field trials the company will need to obtain CE Approval...but this is a very big step forward....imo | barrywhit | |
01/6/2015 08:14 | Morning, I am new here, could someone advise how long the next step is likely to take before commercialisation ? The news release stated; "will now be subject to verification and validation leading to the release of Visitect(R) CD4 test devices for re-evaluation in the field." Six months? A year? or longer. Thanks. Nice professional thread here. | pdt | |
01/6/2015 08:07 | Could be that we will now see a few director buys...... | barrywhit | |
01/6/2015 08:05 | Hard to pick up any in quantity this morning. Mms appear to have closed the doors. | longshanks |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions